乳腺癌前哨淋巴结作为医疗质量的指标：哥伦比亚的统计评估。
Sentinel node in breast cancer as an indicator of quality in medical care: Evaluation of statistics in Colombia.
机构信息
Department of Obstetrics and Gynecology, Faculty of Medicine, Universidad Nacional de Colombia, Bogotá D.C, Colombia.
出版信息
Breast Dis. 2024;43(1):65-69. doi: 10.3233/BD-230059.
BACKGROUND
Sentinel lymph node biopsy in breast cancer is considered the standard of staging in cases of clinically negative lymph nodes. Its omission in favor of axillary dissection generates significant morbidity.
OBJECTIVE
To determine the total number of sentinel node biopsy procedures in breast cancer in Colombia from 2017 through 2020, model and analyze them as if they were performed only in stage I breast cancer patients, and integrate their results into the concepts of quality of medical care.
METHODS
Search in a database of the Ministry of Health and Social Protection of Colombia with sentinel lymph node biopsy codes, and filters of breast cancer and year. Their results are contrasted with the number of cases in stage I of breast cancer.
RESULTS
Breast cancer TNM staging was reported in 22154 cases, 3648 stage I. In the same time frame, the number of sentinel lymph node biopsies for breast cancer in Colombia was 1045, 28.64% of the total cases reported in stage I.
CONCLUSIONS
Colombia is far from complying with the standard indicator of sentinel lymph node biopsy. It is recommended to concentrate breast cancer cases in hospitals that provide the conditions for its performance.
背景
在临床淋巴结阴性的情况下，前哨淋巴结活检被认为是乳腺癌分期的标准。为了避免腋窝清扫而放弃前哨淋巴结活检会导致显著的发病率。
目的
从 2017 年到 2020 年，确定哥伦比亚乳腺癌前哨淋巴结活检的总数，并对其进行建模和分析，假设它们仅在 I 期乳腺癌患者中进行，并将其结果纳入医疗质量的概念中。
方法
在哥伦比亚卫生部和社会保障部的数据库中搜索前哨淋巴结活检的代码，并对乳腺癌和年份进行筛选。将结果与 I 期乳腺癌的病例数进行对比。
结果
报告了 22154 例乳腺癌 TNM 分期病例，其中 I 期 3648 例。在同一时期，哥伦比亚乳腺癌前哨淋巴结活检的数量为 1045 例，占 I 期报告病例总数的 28.64%。
结论
哥伦比亚远未达到前哨淋巴结活检的标准指标。建议将乳腺癌病例集中在能够提供该检查条件的医院。
Zotero 插件